Xiongjun Zhou
About Xiongjun Zhou
Xiongjun Zhou is an R&D Software Engineer with extensive experience in maintaining and upgrading proton treatment systems. He has worked at IBA since 2014, providing technical support for SCADA systems and databases, and holds degrees in Engineering Mechanics and Computer Application Technology.
Work at IBA
Xiongjun Zhou has been employed at IBA in the Dallas/Fort Worth Area since 2017 as an R&D Software Engineer. Prior to this role, he worked as a Software Engineer at IBA from 2011 to 2014 and again from 2014 to 2017. His responsibilities include providing technical support and maintenance for proton treatment systems, with a focus on SCADA systems, PLC, B&R systems, and PostgreSQL databases. He has also been involved in on-site upgrades for proton treatment systems, contributing to enhancements in functionality and performance.
Education and Expertise
Xiongjun Zhou holds a Bachelor of Engineering (B.E.) in Engineering Mechanics from Northwestern Polytechnical University, where he studied from 2001 to 2005. He further advanced his education by obtaining a Master of Engineering (M.Eng.) in Computer Application Technology from the Graduate University of the Chinese Academy of Sciences, completing his studies from 2005 to 2008. His academic background supports his expertise in maintaining and upgrading complex systems used in medical technology, particularly in proton therapy.
Background
Before joining IBA, Xiongjun Zhou worked as a Software Developer at Casco Signal in Shanghai City, China, from 2008 to 2010. This experience contributed to his foundational skills in software development, which he has applied in his subsequent roles in the medical technology sector.
Professional Experience
Xiongjun Zhou has accumulated significant professional experience in software engineering, particularly in the field of medical technology. His roles have involved technical support, system maintenance, and upgrades for proton treatment systems, showcasing his ability to work with complex technological systems. His tenure at IBA has been marked by a focus on enhancing the performance of medical treatment systems.